TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis

Anne Kallehauge Nielsen, Jonas Folke, Sylwia Owczarek, Kirsten Svenstrup, Kristian Winge, Bente Pakkenberg, Susana Aznar, Tomasz Brudek


OBJECTIVE: We hypothesize alterations in the quality and quantity of anti-43-kDa TAR DNA-binding protein (TDP-43) naturally occurring autoantibodies (NAbs) in patients with amyotrophic lateral sclerosis (ALS); therefore, we assessed relative binding properties of anti-TDP-43 NAbs composite in plasma from patients with ALS in comparison with healthy individuals.

METHODS: ELISA competition assay was used to explore the apparent avidity/affinity of anti-TDP-43 NAbs in plasma from 51 normal controls and 30 patients with ALS. Furthermore, the relative levels of anti-TDP-43 NAbs within the immunoglobulin (Ig) classes of IgG (isotype IgG1-4) and IgMs were measured using classical indirect ELISA. The occurring results were hereafter correlated with the measures of disease duration and disease progression.

RESULTS: High-avidity/affinity anti-TDP-43 NAbs levels were significantly reduced in plasma samples from patients with ALS. In addition, a significant decrease in relative levels of anti-TDP-43 IgG3 and IgM NAbs and a significant increase in anti-TDP-43 IgG4 NAbs were observed in ALS plasma vs controls. Furthermore, a decrease in global IgM and an increase in IgG4 levels were observed in ALS. These aberrations of humoral immunity correlated with disease duration, but did not correlate with ALS Functional Rating Scale-Revised scores.

CONCLUSIONS: Our results may suggest TDP-43-specific immune aberrations in patients with ALS. The skewed immune profiles observed in patients with ALS could indicate a deficiency in the clearance capacity and/or blocking of TDP-43 transmission and propagation. The decrease in levels of high affinity/avidity anti-TDP-43 NAbs and IgMs correlates with disease progression and may be disease predictors.

TidsskriftNeurology: Neuroimmunology and NeuroInflammation
Udgave nummer2
StatusUdgivet - mar. 2021


Dyk ned i forskningsemnerne om 'TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis'. Sammen danner de et unikt fingeraftryk.